C. Hultén, R. M. Tulamo, M. M. Suominem, K. Burwall, G. Marhaug and M. Forsberg, “A Non-Competitive Chemiluminescence Enzyme Immunoassay for the Equine Acute Phase Protein Serum Amyloid A (SAA)—A Clinically Useful Inflammatory Marker in the Horse,” Veterinary Immunology Immunopathology, Vol. 68, No. 2-4, 1999, pp. 267-281. doi:10.1016/S0165-2427(99)00027-6

has been cited by the following article:

• TITLE: Factors Influencing Serum Amyloid Type A (Saa) Concentrations in Horses

  AUTHORS: Katy Satué, Antonio Calvo, Juan Carlos Gardón

  KEYWORDS: Acute Phase Response; Serum Amyloid A; Equine

  JOURNAL NAME: Open Journal of Veterinary Medicine, Vol.3 No.1, March 27, 2013

  ABSTRACT: The acute phase response (APR) is the reaction that occurs in animals in response to disturbances in hemostasis following tissue damage. In horses, the APR is manifested in a variety of pathological processes of various origins, such as infections caused by bacteria, viruses, parasites, arthritis, burns, chemicals, trauma surgery and stress. Acute phase proteins (APPs) are considered those proteins that modify its plasma concentration at least 25% in inflammatory and infectious processes. In adult horses, various respiratory inflammatory processes, gastrointestinal tract, reproductive organs and musculoskeletal system are accompanied by increased levels of a specific APP, so-called serum amyloid type A (SAA). SAA is the most important major APP in the horse. This paper provides a review of physiological factors affecting SAA levels and their role in horses in defense of natural mechanisms, the pathways involved and their material components.